If changes in the global gadolinium market make it harder to source the fluid, “patient care will suffer,” said Thomas Grist, a professor of radiology at the University of Wisconsin-Madison. “It’s a very important agent to enhance contrastfor MRI,” he added, explaining there are no direct alternatives.